Eurosarcoidosis inaugurates Scientific Advisory Board
Woerden, Netherlands, 19 February 2024 – Eurosarcoidosis, the Eurosarcoidosis Research Fund, has appointed a seven-member Scientific Advisory Board. The Board will advise on research policies, priorities and opportunities, and become operational from March 2024.
“The Executive Board of Eurosarcoidosis is pleased to welcome seven eminent and dedicated scientists with deep knowledge of the state of global sarcoidosis research. We have asked them to focus on the design of a draft European Sarcoidosis Research Agenda, which will be circulated for discussion among the medical and scientific communities,” mr Jules Prast, Eurosarcoidosis chairman, stated. “Their support for this initiative will make a world of difference to engage donors and other stakeholders for the Fund’s ambition to create a European fund for sarcoidosis research”, he continued.
Sarcoidosis or Besnier Boeck disease is a rare and disabling chronic inflammatory disorder with no known cause and no cure. Nodules of inflammatory cells, called granulomas, may interfere with the proper functioning of any organ or tissue in the human body. Fatigue is a hallmark of the disease, which may continue even after inflammatory activity itself has abated. Mortality, mostly due to pulmonary and cardiac complications, ranges between six and eight per cent.
—
Media inquiries:
Eurosarcoidosis
info@eurosarcoidosis.org
+31 34 8 890 890